The number of common shares issued to each common stock outstanding in consideration for the business combination.

No definition available.

Name:	armp_BusinessCombinationConsiderationTransferredNumberOfSharesIssuedToEachShareOutstanding
Namespace Prefix:	armp_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The percentage of aggregate number of shares of common stock and security holders.

+ References

No definition available.

+ Details

Name:	armp_CommonStockPercentageOfAggregateNumberOfSharesAndSecurityHolders
Namespace Prefix:	armp_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Expected purchase price per share of the combined entity pursuant to Share Purchase Agreement.

+ References

No definition available.

+ Details

Name:	armp_ExpectedPricePerShareOfCombinedEntity
Namespace Prefix:	armp_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the numerator used for determination of per share price of Share Purchase Agreement.

+ References

No definition available.

+ Details

Name:	armp_NumeratorForDeterminationOfPerSharePriceOfSharePurchaseAgreement
Namespace Prefix:	armp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The method of determining the fair value of the equity interests of the acquirer, including the number of instruments or interests issued or issuable in consideration for the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

+ Details

Name:	us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	dei_LegalEntityAxis=armp_AmpliphiBiosciencesCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=armp_C3jTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementScenarioAxis=us-gaap_ScenarioPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=armp_C3jTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=armp_AgreementAndPlanOfMergerAndReorganizationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) $ / shares in Units, $ in Millions					9 Months Ended
	May 09, 2019 shares	Feb. 05, 2019 USD ($) $ / shares	Jan. 03, 2019 USD ($) shares	Apr. 24, 2017	Sep. 30, 2019
Subsequent Event [Line Items]
Reverse stock split ratio					0.0714
AmpliPhi Biosciences Corporation [Member]
Subsequent Event [Line Items]
Reverse stock split ratio				10
Percentage of ownership	24.00%
C3J [Member]
Subsequent Event [Line Items]
Number of shares issued per common stock outstanding	0.6906
Reverse stock split ratio	0.0714
Percentage of ownership	76.00%
Scenario, Plan [Member] \| AmpliPhi Biosciences Corporation [Member]
Subsequent Event [Line Items]
Expected price per share of combined entity \| $ / shares		$ 0.36
Subsequent Event [Member] \| AmpliPhi Biosciences Corporation [Member]
Subsequent Event [Line Items]
Commitment to invest in the combined company \| $			$ 10.0
Common stock purchased upon closing of merger, value		$10.0
Numerator for determination of per share price of Share Purchase Agreement \| $		$ 40.0
Subsequent Event [Member] \| C3J [Member]
Subsequent Event [Line Items]
Number of shares issued per common stock outstanding	0.6906
Reverse stock split ratio	0.0714
Subsequent Event [Member] \| C3J [Member] \| Agreement and Plan of Merger and Reorganization [Member] \| AmpliPhi Biosciences Corporation [Member]
Subsequent Event [Line Items]
Number of shares issued per common stock outstanding			0.6892
Percentage of ownership			30.00%
Subsequent Event [Member] \| C3J [Member] \| Agreement and Plan of Merger and Reorganization [Member] \| C3J [Member]
Subsequent Event [Line Items]
Percentage of ownership			70.00%
Subsequent Event [Member] \| C3J [Member] \| Agreement and Plan of Merger and Reorganization [Member] \| Minimum [Member] \| AmpliPhi Biosciences Corporation [Member]
Subsequent Event [Line Items]
Reverse stock split ratio			0.33
Subsequent Event [Member] \| C3J [Member] \| Agreement and Plan of Merger and Reorganization [Member] \| Maximum [Member] \| AmpliPhi Biosciences Corporation [Member]
Subsequent Event [Line Items]
Reverse stock split ratio			0.05